anonymous
Guest
anonymous
Guest
Well let's hear a round of applause for the big finance boy. Very impressive. You just made yourself look foolish. The stock has been pitiful and investors do look at F rating as it shows the volatility. Maybe spend some more time with your accounting buddies in Ann Arbor and figure out a way to launch this turd of a drug. The launch has been a miserable failure. Even a community college dropout can see this. Your not impressive. Actually any of the Esperion Minions that come onto cafepharma display unbelievable arrogance and have a hard time facing the fact that they failed in their last jobs. The RD's only quest in interviews was to poach information as they didn't have a clue about the market. I've talked to at least 10 people who went through interviews and everyone the interviewer and no interest in past accomplishments or rankings. The only they wanted to see were business plans, top doctor lists, managed care lists, speaker bureau list and help in cutting out territories. So don't sit there and tell us how ethical or how the scientific process is being duplicating by others company. Totally false. Documented facts that reps that were hired weren't the best of the best. This is where Esperion has really dropped the ball and will dictate to a failed drug. You can't win with C players. Reps totally mislead Esperion on their accomplishments. The RD's were the most unimpressive bunch we've seen in our careers. Esperion will get sold off eventually and the All Star team disbanded. So just head back into your circle jerk Ann Arbor meetings and continue to tell us of all the clamoring going on with the medical community.
Accurate. The interview process set the stage for a lousy culture at Esperion.